SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is under intense scrutiny as it celebrates its 50th anniversary, facing a dual narrative of potential long-term growth through its push into budget-friendly hardware and immediate volatility driven by reported engineering delays on its foldable iPhone and patent infringement setbacks in China. Investors are closely monitoring how the company balances its massive cash reserves against potential settlement costs, while the community remains divided between those bullish on its core ecosystem stability and others wary of its lagging position in the aggressive AI integration race.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant price volatility as investors react to the CMS finalization of a 2027 Medicare Advantage rate hike, which came in stronger than previously feared projections. While some market participants are celebrating this as a major relief rally and a catalyst for a short squeeze, others remain cautious due to ongoing sector-wide regulatory uncertainty and concerns over broader market pressures.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending following the formalization of a long-term AI silicon partnership with Google through 2031, which includes custom TPU development and compute capacity commitments for Anthropic. While the community is actively debating the stock's technical support levels and broader sector volatility, many traders are highlighting the deal as a major structural catalyst that reinforces Broadcom's leadership in the hyperscale AI infrastructure space.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is facing significant downward pressure as investors weigh premium valuation concerns and potential macro sensitivity against its role as a key data provider for AI model training. The community is sharply divided, with bulls pointing to the company's long-term data licensing potential and share buyback program, while bears highlight heavy insider selling, concerns over bot-inflated user metrics, and the platform's broader content moderation controversies.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana and other managed care stocks are surging following a finalized Medicare Advantage payment rate from CMS that exceeded initial market fears and projections. Investors are actively discussing the revenue stability this decision provides for the sector, while others remain focused on navigating volatility and assessing the long-term impacts of policy shifts on insurer margins.

Space and Time is the data blockchain securing onchain finance. Backed by Microsoft’s Venture Fund M12, Space and Time connects real-world data to onchain systems to power tokenized assets, stablecoins, institutional markets, and DeFi.  The SXT token is deployed as an ERC-20 token on Ethereum and functions as the network's native utility token. SXT is used for staking, data processing payments, access control, and incentives for data contributors.

Space and Time

Space and Time (SXT) is gaining significant community traction due to its high-profile technological partnerships, including integrations with Microsoft and Samsung, as well as its focus on verifiable, AI-ready data infrastructure. While some investors are bullish on the project's long-term potential and institutional backing, others are debating the impact of recent token unlocks and questioning its short-term price volatility.

AleAnna, Inc. operates as a technology-driven energy company, which engages in supplying low-carbon natural gas and renewable natural gas to Italy. The company was founded in 2007 and is headquartered in Dallas, TX.

AleAnna Inc. - Ordinary Shares - Class A

AleAnna Inc. is at the center of intense market activity driven by escalating geopolitical tensions in the Middle East and concerns over energy supply disruptions. The community is actively debating the stock's potential as a long-term play on European natural gas needs while closely monitoring the impact of volatile news cycles and heavy institutional short-selling.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending following a significant leadership overhaul that replaced CEO Peter Greenleaf with Chairman Kevin Tang, a move that the community widely interprets as a clear signal that the company is being positioned for a potential buyout. Investors are closely monitoring how Tangs new management team will leverage existing assets, such as Lupkynis and the Aritinercept pipeline, to maximize shareholder value.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is in the spotlight as investors await upcoming Phase 2 pediatric trial data for zelicapavir, which the company expects to provide insights into its RSV treatment strategy. Community sentiment remains focused on the potential of Enanta's RSV portfolio and immunology pipeline to address significant unmet market needs despite recent volatility and broader competitive pressures in the biotech sector.

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Bausch + Lomb Corp

Bausch + Lomb Corp.

Bausch + Lomb is currently a focal point of intense market speculation as activist investor JANA Partners builds a stake in The Cooper Companies, aiming to orchestrate a strategic merger or separation involving their contact lens division and $BLCO. This move has sparked enthusiasm among market participants who view the potential consolidation as a major value-unlocking catalyst, though discussions remain shadowed by concerns over the company's long-term debt structure and its complex relationship with parent firm Bausch Health.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies upgraded its rating on PVH Corp (PVH), the fashion company that runs Tommy Hilfiger and Calvin Klein, to 'Buy', citing its improving business prospects.PVH shares rose 8.4% to their highest level in about four months.The investment firm upgraded its rating from 'Hold' and also bumped the price target to $105 from $70 earlier, according to The Fly. The new target signals a 20% upside to PVH's last closing price.Jefferies noted that PVH’s new leadership efforts and the easing of prior one-time challenges are expected to restore sales growth to the low single digits — a key factor supporting the stock.The firm also anticipates that cost reductions and share repurchases will help drive earnings growth into the high single digits this year.PVH had announced a $500 million buyback plan last month.Jefferies' upgrade follows&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pvh-corp-stock-soars-after-hours-on-q4-beat-strong-2025-view/chf2gnPRb4U">strong results</a> from PVH for the last quarter.Revenues declined less than expected, at 4.8%, and profit exceeded expectations.CEO Stefan Larsson said in April that PVH was making headway with consumers in its key markets, such as North America, Europe, and Asia Pacific.On Stocktwits, retail sentiment turned 'bullish' from 'bearish' the previous day, and message volume rose to 'high.'<figure class="image"><img style="aspect-ratio:632/68;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_15_at_8_46_39_AM_png_52848765c4.webp" alt="Screenshot 2025-05-15 at 8.46.39 AM.png" width="632" height="68"><figcaption>PVH sentiment and message volume as of May 14 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/PVH">PVH stock</a> is down 17.5% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

People walk past a Tommy Hilfiger luxury fashion label store in Knightsbridge on February 17, 2025 in London, United Kingdom. (Photo by John Keeble/Getty Images)

Jefferies Upgrades To PVH To 'Buy' On Expected Return To Sales Growth: Retail Turns Bullish

The analyst said new leadership efforts and easing prior one-time challenges are expected to boost sales and stock price.

Equity

The analyst said new leadership efforts and easing prior one-time challenges are expected to boost sales and stock price.


PVH Corp (PVH) shares surged 16.2% in after-hours trading on Monday, after the company reported better-than-expected fourth-quarter results and provided an upbeat forecast, even as retail investors took a bearish view."In a challenging macro, we delivered another year of strong profitability in North America, drove sequential improvements in our wholesale order books in Europe while improving our quality of sales, and we achieved our third consecutive year of growth in Asia Pacific, on a constant currency basis," CEO Stefan Larsson said in a statement.The company, which owns brands such as Tommy Hilfiger and Calvin Klein, said revenue fell 4.8% to $2.37 billion. Analysts had estimated $2.33 billion, from LSEG/Reuters.Adjusted earnings of $3.27​​ per share were higher than the $3.21 per share estimate.Fourth-quarter revenue was impacted by a 3% decline from the extra week in 2023 and a 1% drop from the sale of its Heritage Brands women’s intimates business, the company said.For fiscal 2025, PVH said it expects revenue to be flat to slightly higher compared to 2024 on both a reported and constant currency basis.It projected adjusted earnings of $12.40 to $12.75 per share, higher than the estimate of $11.68.PVH also announced a $500 million share repurchase plan.The earnings report, however, did not include commentary on the potential impact of the U.S. trade tariffs, which have weighed the outlook for all kinds of retailers, and the risks to the company's business in China.The Asian country recently added PVH to its “Unreliable Entity” list due to certain alleged mispractices, and the characterization could attract penalties and restrictions.Details are expected during PVH's analyst call on Tuesday at 9 a.m. ET.On Stocktwits, retail sentiment for PVH notched lower in the 'extremely bearish' territory, with 'extremely high' message volume.A user said that PVH is not a safe bet owing to its high dependence on Chinese factories and a broadly&nbsp;weak market.<stembedurl>https://stocktwits.com/Malecat/message/609864891</stembedurl>Another user said the buyback could send the stock to $120 to $140 in three to six months.<stembedurl>https://stocktwits.com/LittleIslandforBoys/message/609868069</stembedurl>As of Monday's close, shares of the company are down 39% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

PVH Stock Soars After-Hours On Q4 Beat, Strong 2025 View: Retail Awaits More Details From Earnings Call

For fiscal 2025, PVH expects revenue to be flat to slightly higher compared to 2024 on both a reported and constant currency basis.

PVH Corp (PVH) is expected to report another quarter with negative revenue growth on Tuesday, underscoring the continued weakness in demand for premium apparel and accessories.PVH, the parent of apparel and accessory brands Tommy Hilfiger, Calvin Klein, and Heritage Brands, is scheduled to report fourth-quarter results before the markets open.Adjusted sales during the period are expected to drop 6.3% to $2.33 billion, according to analyst estimates from Koyfin. Growth was negative in all of the preceeding three quarters.Adjusted earnings per share (EPS) is seen at $3.21 compared to $3.72 a year ago.Shares of the company closed nearly 3% lower on Friday and fell further in after-hours trading.Besides its view on wider demand trends, PVH’s comments on its situation in China will be closely monitored, according to analysts.Last month, China added PVH to its “Unreliable Entity” list due to its alleged discriminatory measures against Chinese businesses, particularly concerning a boycott of Xinjiang-sourced cotton.This designation may lead to fines, trade restrictions, and investment limitations, jeopardizing PVH’s access to Chinese manufacturing and consumers.China represented 6% of PVH’s sales and 16% of its earnings before interest and taxes (EBIT) in 2023, although the risk to its manufacturing base is the bigger concern.Last week, at least two analysts, Citi and Telsey Advisory,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/pvh-corp-falls-after-citi-telsey-cut-price-targets/chJGAdORb3B">lowered</a> their price targets on the company, citing a lack of visibility in the Chinese market.On Stocktwits, the retail sentiment improved to 'neutral' from 'bearish a week back, while message volume was 'high'.<figure class="image"><img style="aspect-ratio:716/169;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_31_at_1_56_37_PM_png_5e06fb1f17.webp" alt="Screenshot 2025-03-31 at 1.56.37 PM.png" width="716" height="169"><figcaption>PVH sentiment and message volume as of March 30 | Source: Stocktwits</figcaption></figure>One user said that core brands Tommy and Calvin look resilient despite macro challenges, and they would buy the stock on the dip if the China issue clears.<stembedurl>https://stocktwits.com/NVDAMillionaire/message/609644692</stembedurl>PVH shares are down 39% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

PVH Expected To Report Revenue Degrowth in Q4, China Situation In Focus: Retail Investors In Wait-And-Watch Mode

China has added PVH to its “Unreliable Entity” list due to its alleged discriminatory measures against Chinese businesses. The title may attract fines and restrictions.

Shares of PVH Corp (PVH) closed 3.6% lower on Tuesday and fell further in post-market hours trading after at least two Wall Street analysts cut their price&nbsp;targets.PVH, the parent of apparel and accessory brands Tommy Hilfiger, Calvin Klein and Heritage Brands, is scheduled to report fourth-quarter results on April 1.On Tuesday, Citi lowered its PT on the company's shares to $72 from $123, and maintained a 'neutral' rating, according to The Fly.&nbsp;Telsey Advisory lowered its PT to $90 from $130 while keeping an 'outperform' rating.The volatile macro environment and lack of visibility in China could lead PVH to guide sales and EBIT (earnings before income and tax) margin flat to down, Citi analysts said in their note.They added that although expectations from PVH are low, with China's overhang likely to remain, investors may be hesitant to invest in the stock.The company has faced challenges, including being blacklisted by China’s Ministry of Commerce over alleged boycotts of Xinjiang cotton products, impacting its operations in the country.&nbsp;&nbsp;Additionally, it has been navigating a complex retail landscape marked by macroeconomic challenges, particularly in Europe.Telsey analysts said they were pleased with PVH's initiatives to boost consumer engagement and marketplace sales, which would aid gross margins.On Stocktwits, the retail sentiment improved marginally but held in the 'bearish' territory. Message volume jumped 700% in the past 24 hours.<figure class="image"><img style="aspect-ratio:745/183;" src="https://news.stocktwits-cdn.com/Screenshot_2025_03_26_at_2_23_32_PM_png_fa3c97831e.webp" alt="Screenshot 2025-03-26 at 2.23.32 PM.png" width="745" height="183"><figcaption>PVH sentiment and message volume as of March 25, 2025 | Source: Stocktwits</figcaption></figure>A user posted that, following the PT revisions, the company might not be looking good heading into the earnings.<stembedurl>https://stocktwits.com/BullYa/message/609158588</stembedurl>Another countered by saying the company had good fundamentals.<stembedurl>https://stocktwits.com/Fizz26/message/609026961</stembedurl>PVH shares ended at $66.78 on Tuesday, down 37% year to date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

PVH Corp Falls After Citi, Telsey Cut Price Targets Ahead Of Q4 Print: Retail Mood Bearish

PVH has faced challenges including being blacklisted by China’s Ministry of Commerce over alleged boycotts of Xinjiang cotton products, impacting its operations in the country.

Shares of Urban Outfitters Inc. ($URBN) were down 1.99% on Tuesday afternoon ahead of the company’s third-quarter earnings, but retail sentiment inched up.Wall Street analysts expect Urban Outfitters to announce earnings of $0.86 per share on revenues of $1.34 billion. The company is set to announce results after the market closes on Tuesday.For its second quarter, Urban Outfitters’ EPS stood at $1.24 on revenues of $1.35 billion, beating estimates. “We are pleased to report record second-quarter sales fueled by strength across all three segments – Retail, Nuuly and Wholesale,” Richard A. Hayne, CEO of Urban Outfitters, said at the time.Retail sentiment on the stock improved to ‘neutral’ (51/100) from ‘bearish’ (25/100) a day ago. Message volumes remained in the ‘high’ zone.<figure class="image"><img style="aspect-ratio:1304/290;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_11_27_at_1_43_22_AM_fc5d6cbf71.png" alt="Screenshot 2024-11-27 at 1.43.22 AM.png" width="1304" height="290"><figcaption>URBN sentiment meter and message volumes on Nov 26 as of 3:15 pm ET| Source: Stovktwits</figcaption></figure>Last week, Citi raised the company’s price target to $42 from $39 while keeping a ‘Neutral’ rating, The Fly.com <a target="_blank" rel="noopener noreferrer nofollow" href="https://thefly.com/news.php?symbol=URBN">reported.</a> According to the firm, a Q3 earnings beat was likely driven by stronger-than-consensus gross margins. “Warmer weather headwinds” were temporary, according to the firm, while its “Free People and Anthropologies comps” are holding up relatively well, the report added.Citi’s prediction for the company’s Q4 guidance is a “conservative approach,” with consumers choosing to show up for the holiday season.Philadelphia-based Urban Outfitter’s portfolio includes global brands such as Anthropologie, Free People, FP Movement, and Nuuly.Urban’s stock is up 11.11% year-to-date.For updates and corrections email newsroom[at]stocktwits[dot]com.&nbsp;&nbsp;

Retail sentiment on the stock improved to ‘neutral’ from ‘bearish’| Source: Wikimedia Commons

Urban Outfitters Stock Slips Ahead Of Q3 Earnings: Retail’s Neutral

Wall Street analysts expect Urban Outfitters to announce earnings of $0.86 per share on revenues of $1.34 billion. 

Current Price	$52.67
Prev Close	$52.27
Open	$52.11
Dividend Yield	N/A
50-Day Moving Average	$52.28
Beta	N/A
Avg. Volume	24,122.21
PE Ratio	N/A

52-Week High	$54.12
52-Week Low	$36.77
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

QVAL
Alpha Architect Etf Trust - Alpha Architect U.S. Quantitative Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest QVAL News

QVALAlpha Architect Etf Trust - Alpha Architect U.S. Quantitative Value ETF